Establishment and characterization of a new human eosinophilic leukemia cell line
- PMID: 2415185
Establishment and characterization of a new human eosinophilic leukemia cell line
Abstract
A human eosinophilic leukemia cell line, designated as EoL, was established from the peripheral blood of a patient with Philadelphia chromosome-negative eosinophilic leukemia (EL). The EoL cell line grows in single cell suspension with a doubling time of 48 hours for about one year. The reactivity of these cells was tested with a panel of monoclonal antibodies; they were found to express surface IA antigen, myeloid antigen (IF10, MY9) and membrane receptors for interleukin 2 (IL-2, Tac antigen). Under standard culture conditions, a small percentage of cells having more typical eosinophilic characteristics was present. These cells had cytoplasmic granules and were positive for Luxol-fast-blue and eosinophil peroxidase. Under culture conditions to induce the maturation of myeloid cells, such as alkaline medium or addition of dimethyl sulfoxide (DMSO), the frequency of cells with typical eosinophilic features increased to about 40%. In addition, cytogenetic studies showed that cultured cells and original leukemic blasts presented similar chromosome abnormalities. EoL seems to be a unique leukemic line committed to the eosinophilic lineage and can provide a useful in vitro model for the study of malignant eosinophilic properties.
Similar articles
-
Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome.Blood. 1985 Dec;66(6):1384-92. Blood. 1985. PMID: 2998511
-
Differentiation of a human eosinophilic leukemia cell line (EoL-1) by a human T-cell leukemia cell line (HIL-3)-derived factor.Blood. 1991 Apr 15;77(8):1766-75. Blood. 1991. PMID: 1707698
-
Models of lineage switching in hematopoietic development: a new myeloid-committed eosinophil cell line (YJ) demonstrates trilineage potential.Leukemia. 1998 Sep;12(9):1430-9. doi: 10.1038/sj.leu.2401115. Leukemia. 1998. PMID: 9737693
-
[Review: recent studies on a human eosinophilic leukemia cell line, EoL as an experimental model of eosinophils].Nihon Rinsho. 1993 Mar;51(3):712-7. Nihon Rinsho. 1993. PMID: 8098379 Review. Japanese.
-
EoL-1, a human eosinophilic cell line.Leuk Lymphoma. 1992 Jun;7(3):243-50. doi: 10.3109/10428199209053629. Leuk Lymphoma. 1992. PMID: 1477652 Review.
Cited by
-
Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils.Clin Exp Immunol. 2003 Mar;131(3):436-45. doi: 10.1046/j.1365-2249.2003.02090.x. Clin Exp Immunol. 2003. PMID: 12605696 Free PMC article.
-
Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.Clin Exp Immunol. 1991 May;84(2):283-8. doi: 10.1111/j.1365-2249.1991.tb08162.x. Clin Exp Immunol. 1991. PMID: 2025954 Free PMC article.
-
Activation of beta1 integrins on blood eosinophils by P-selectin.Am J Respir Cell Mol Biol. 2011 Oct;45(4):889-97. doi: 10.1165/rcmb.2010-0402OC. Epub 2011 Mar 25. Am J Respir Cell Mol Biol. 2011. PMID: 21441381 Free PMC article.
-
1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.J Clin Immunol. 1994 Jan;14(1):50-60. doi: 10.1007/BF01541175. J Clin Immunol. 1994. PMID: 8132737
-
Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation.Biochem J. 1995 Feb 1;305 ( Pt 3)(Pt 3):829-35. doi: 10.1042/bj3050829. Biochem J. 1995. PMID: 7848283 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
